Viewing nowCombinationTelmisartan and Amlodipine Tablets 40/10 mg
Telmisartan 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Jaeil Health Science Co., Ltd.

MFDS item code 201907044 · Approved 2019.10.04 · Insurance code 054301110
Treatment of essential hypertension not controlled with monotherapy
This medication can effectively lower blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with Amlodipine or Telmisartan alone. By managing blood pressure appropriately, it helps reduce the risk of cardiovascular complications and maintain health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the dose be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should not be used in pregnant women or women of childbearing potential, especially during the second and third trimesters, as it can pose serious risks to the fetus. It should not be administered to patients with certain conditions, such as severe liver dysfunction, severe valvular heart disease, severe hypotension, cardiogenic shock, and unstable heart failure after acute myocardial infarction. Additionally, due to its strong blood pressure-lowering effects, special caution should be taken when administering this medication to patients with primary aldosteronism, renal vascular disease, active gastrointestinal disease, the elderly, and patients with reduced kidney function. This medication lowers blood pressure and may lead to symptoms of hypotension; if such symptoms occur, the patient should be laid down and intravenous fluid treatment should be initiated if necessary. It may increase serum potassium levels, so patients at risk of hyperkalemia must have their potassium levels monitored regularly through blood tests. If this medication is taken during pregnancy, there may be renal function abnormalities or skull formation defects in the fetus, so the fetal condition should be monitored regularly. It is not recommended for nursing women, and its use should be avoided during breastfeeding. Possible side effects include dizziness, peripheral edema, headache, fatigue, and if any symptoms are severe, consultation with healthcare professionals should be sought. During treatment, caution is required when driving or operating dangerous machinery, as drowsiness or dizziness may occur. Interactions may occur when taken with other medications, so patients taking diuretics, potassium supplements, lithium, digoxin, warfarin, etc., should inform their healthcare provider. In case of overdose, severe hypotension, tachycardia, dizziness, and acute renal failure may occur, so immediate medical attention is required for appropriate treatment. The safety and efficacy of this medication in children have not been sufficiently proven, and its use is not recommended.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and air, and it is best to keep it at a temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a longer period.
This medication is a white, oval, biconvex tablet.
30 tablets/bottle, 30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Jaeil Health Science Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.